Literature DB >> 18781307

[Endophthalmitis after repeated bevacizumab injections].

K B Schaal1, A E Höh, A Scheuerle, S Dithmar.   

Abstract

Symptoms resembling endophthalmitis developed 1 day after the seventh injection of bevacizumab in a 76-year-old woman with extrafoveal occult choroidal neovascularization in conjunction with age-related macular degeneration. The diagnosis reached was an immune reaction with pseudohypopyon after repeated bevacizumab injections. The condition resolved completely within 5 days under sole administration of corticosteroids. Treatment was then continued with pegaptanib and no further intraocular irritation occurred.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18781307     DOI: 10.1007/s00347-008-1843-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

Review 1.  [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

Authors:  G B Jaissle; P Szurman; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

2.  Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; Steven D Schwartz; Mark S Blumenkranz; Joan W Miller; Julia A Haller; James D Reimann; William L Greene; Naveed Shams
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

3.  Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection.

Authors:  Darius M Moshfeghi; Peter K Kaiser; Sophie J Bakri; Richard S Kaiser; Raj K Maturi; Jonathan E Sears; Ingrid U Scott; Jonathan Belmont; Paul M Beer; Hugo Quiroz-Mercado; William F Mieler
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2005 Jan-Feb

4.  Intraocular inflammation following intravitreal injection of bevacizumab.

Authors:  Sophie J Bakri; Theresa A Larson; Albert O Edwards
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-17       Impact factor: 3.117

5.  Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.

Authors:  Mark L Nelson; Matthew T S Tennant; Arunan Sivalingam; Carl D Regillo; Jonathan B Belmont; Adam Martidis
Journal:  Retina       Date:  2003-10       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.